Medicine and Dentistry
Neutralizing Antibody
100%
COVID-19
80%
Severe Acute Respiratory Syndrome Coronavirus 2
78%
Patient
63%
Assay
59%
Vaccine
54%
Estetrol
48%
Blood Stasis
48%
Thrombin
48%
Cells
48%
Antibody
39%
Virus
36%
Humoral Immunity
35%
Woman
34%
Laboratory
33%
Infection
29%
Biological Marker
27%
Bleeding
27%
Drospirenone
24%
Virus Neutralization
24%
Postmenopause
24%
Syndrome
24%
Thrombosis
24%
Bone Turnover
24%
Thrombocytopenia
24%
Human
24%
Observational Study
24%
Coagulopathy
24%
Antigen
24%
Messenger RNA
24%
Activated Protein C Resistance
24%
Immunogenicity
24%
Cytokine Response
24%
Metabolism
24%
Transplantation
24%
Lung
24%
Septic Shock
24%
Nucleosome
24%
Laboratory Medicine
24%
Placebo
24%
Diagnosis
24%
Cellular Immunity
24%
Direct Oral Anticoagulant
24%
Dextran Sulfate
24%
Inpatient
24%
Consensus
24%
Protein
20%
Serum
20%
Neutrophil
18%
Histone
18%
Activated Protein C
17%
Wassermann Test
17%
Carbohydrate Metabolism
16%
Measurement
16%
Immune Response
15%
Lipid
13%
Satisfaction
12%
Arm
12%
Extracellular Trap
12%
Oral Contraceptive Agent
9%
Analysis
9%
Disease
9%
Levonorgestrel
9%
Booster Dose
9%
Serositis
9%
Antithrombotic
8%
Genetic Transfection
8%
Receptor
8%
Host Cell
8%
Receptor Binding
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Virus Infection
8%
Pathogen
8%
Diagnostic Test
8%
Human Cell
8%
Plaque
8%
Influenza
8%
Gamma Interferon
8%
Stimulation
8%
T Cell
8%
Blood
8%
Authority
8%
In Vitro
8%
Drug Dose Regimen
7%
Sex Hormone Binding Globulin
6%
Reproducibility
6%
APC
6%
Screening
6%
Liver Function
6%
Gestagen
6%
Diagnostic Error
6%
Deep Vein Thrombosis
6%
Laboratory Assessment
6%
Post-Analytical Phase
6%
mRNA Vaccine
6%
Corticosteroid
6%
Leukocyte Elastase
6%
Therapeutic Procedure
6%
Low Drug Dose
6%
Thrombocyte Activation
6%
Blood Clotting Factor 10a Inhibitor
6%
Direct Thrombin Inhibitor
6%
Procoagulant
5%
Hemostat
5%
Immunology and Microbiology
Neutralizing Antibody
75%
Binding Antibody
51%
Severe Acute Respiratory Syndrome Coronavirus 2
48%
Antigen
48%
Vaccine Efficacy
36%
Humoral Immunity
27%
COVID-19
24%
Omicron Coronavirus Variant
24%
Lung Transplantation
24%
Laboratory Test
24%
Immunogenicity
24%
Respiratory Syncytial Virus
24%
Cells
24%
Influenza
24%
Breakthrough Infection
24%
Adoptive Immunity
24%
Spike
19%
Thrombin
19%
Clotting Time
14%
Viral Load
13%
Reverse Transcription Polymerase Chain Reaction
12%
Dose
12%
Platelet Factor 4
12%
Monospecific Antibody
11%
Sample
10%
Titer
9%
Screening Test
9%
Booster Dose
9%
Time
8%
Receptor Binding
8%
Viral Entry
8%
Infectious Agent
8%
Surface Property
8%
Viral Disease
8%
Host Cell
8%
Plaque Reduction Neutralization Test
8%
Human Cell
8%
Cytolysis
8%
T Cell
8%
Interferon Gamma
8%
Antibody Titer
7%
Cycle Threshold
6%
Kinetics
6%
Immune Response
6%
Antigen Response
6%
Viremia
6%
Sampling
6%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
79%
Estetrol
48%
Clotting Time
37%
SARS Coronavirus
28%
Diseases
28%
Coronavirinae
28%
Edoxaban
26%
Antigen
24%
Drospirenone
24%
Atrial Fibrillation
24%
Activated Protein C Resistance
24%
Emergency
24%
Blindness
24%
Cytokine
24%
Dexamethasone
24%
Blood Clotting Disorder
24%
Prothrombin
20%
Ethinylestradiol
18%
Placebo
16%
Anticoagulant Agent
13%
Venous Thromboembolism
12%
Inflammation
12%
Estrogen Receptor
12%
Antivitamin K
11%
Heparin
11%
Thromboplastin
10%
Tolerability
10%
Hemostatic Agent
10%
Disease Severity
9%
RNA Directed DNA Polymerase
9%
Blood Clotting Inhibitor
9%
Symptom
9%
Levonorgestrel
9%
Estrogen
8%
Endocrine Therapy
8%
Thromboembolism
8%
Fibrinolytic Agent
6%
Genetic Disorder
6%
Blood Clotting Factor 8
6%
Hormone
6%
Absence
6%
F Factor
6%
Protein S Deficiency
6%
Diethylstilbestrol
6%
Nuclear Estrogen
6%
Clinical Study
5%